It's not all hype many people do feel a real difference
- October 24, 2025 - Rose Pharma Inc., a clinical-stage biopharmaceutical company developing ROSE-010, a rapid-onset, short-duration GLP-1 therapy targeting both weight management and acute IBS pain, today announced that Chief Executive Officer Enda Kenny, PhD will present data from its recent clinical trial in weight management at #ObesityWeek2025 (sponsored by The Obesity Society) on Tuesday, November 4, 2025 at 7:30 p.m
Vegetarians and vegans who lack dietary sources of B12
Whether youre giving yourself an intramuscular or subcutaneous injection, try to avoid giving the shot in the same place twice in a row
High-purity, endotoxin-free Body Protection Compound 157 for laboratory in-vitro research
Its especially beneficial for those with fatigue, mood changes, or dietary deficiencies (common in plant-based diets)